Furthermore, we validated these findings by ‘in silico’ analysis of the publically available REMBRANDT glioma dataset (GlioVis web application), which confirmed the positive correlation between BRCA1 and RRM2 mRNA expression (SCA; P=0.00; CI 0.44–0.57; Fig. 6i). The gene discussed is RRM2; the disease is glioma.